Heart monitors for horses, shaded pens for bulls part of rodeo safety at Calgary Stampede
Tents are being set up to provide shade for bulls and broncs and some chuckwagon horses are to be fitted with tiny electrocardiograms at the upcoming Calgary Stampede.
After scorching heat at the rodeo last summer, Ed Pajor, a professor of animal behaviour and welfare in the University of Calgary's faculty of veterinary medicine, says the animals could use a break.
"We saw things like increased respiration rate in some of the bulls. We saw some bulls drooling. These are signs that the animals might be experiencing some discomfort due to the heat," Pajor said at a news conference Tuesday.
The university is working with the Stampede to study some of the animals this year. They'll specifically look at whether bucking bulls and broncos will be happier and healthier if they have a shady place to hang out right before the competition.
"It seems like a pretty straightforward question," said Pajor, adding if shade is beneficial, the Stampede would have to decide whether to invest in more tent coverings in the future.
Additional research at the rodeo is to focus on the heart health of horses in the chuckwagon races.
Dr. Renaud Léguillette, with the university's veterinary school, specializes in equine health and performance, and works closely with chuckwagon horses during the Stampede.
His research includes identifying in equine blood a baseline for troponin — a protein released when the heart muscle is damaged — to track underlying cardiovascular or other health issues.
"The goal of our research is to prevent cardiac accidents during the chuckwagon racing due to a cardiac problem," said Léguillette.
"There are some horses who have more electrical activity issues when they race or have a harder time to recover from the races."
At the Stampede, outrider horses and horses pulling the wagons are to be fitted with electrocardiograms before and during the races.
Léguillette said the devices and the blood tests can show what horses are at a higher risk of cardiac arrest and that information is passed on to chuckwagon drivers.
"I call it like a green light, an orange light and a red light. The red light horses, I will definitely have a discussion with the drivers ... they are very responsive, concerned and will make the right decisions."
An official with the Stampede said research in this area could benefit an entire industry.
"We know there is an element of risk in all sport. Our goal is to create the safest conditions possible. That's why all of this research takes place ... to remove all of those elements of risk," said Kristina Barnes, the Stampede's director of agriculture and western events.
"Can we remove completely that element of risk? No. But anything that we can control we certainly will."
The 10-day celebration of western culture, which runs from July 4 to 13, has long been a target of animal rights groups. The Vancouver Humane Society wants the rodeo portion of the Stampede eliminated.
"We're seeing deaths at the Calgary Stampede almost every single year. It's really not a matter of if another animal will die at the Stampede ... it's when," said Chantelle Archambault with the group.
"Last year, there were four animal deaths. It also marks at least 109 animal deaths at the Stampede since we began tracking fatalities in 1986."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Partnership Promotes Indigenous Mothers' Reproductive Health
Canada's Indigenous History Month is an appropriate time to examine the efforts that the Canadian Institutes of Health Research (CIHR) are taking to improve Indigenous health trajectories within the First Nations, Inuit, and Métis communities. Many of these efforts flow through the agency's Indigenous Healthy Life Trajectories Initiative (I-HeLTI), which is dedicated to creating transparent, community-first approaches to research and healthcare delivery. 'The goal of I-HeLTI is to identify culturally strengthening strategies crucial for improving maternal and child health outcomes in Indigenous communities,' Chelsea Gabel, PhD, scientific director of the Institute of Indigenous Peoples' Health at CIHR and associate professor of Indigenous studies and health, aging, and society at McMaster University in Hamilton, Ontario, told Medscape Medical News. Gabel is a Red River Métis. Chelsea Gabel, PhD 'Research shows that First Nations, Inuit, and Métis people experience significantly higher rates of noncommunicable diseases, as well as issues around maternal health and poor health outcomes in general,' she said. Research on Indigenous communities historically has focused on deficits. 'This means that it's focused on a larger problem (eg, Indigenous people are more likely to have diabetes or drink more) vs looking at [the role played by] factors like intergenerational trauma, the residential schools system, and social determinants of health.' I-HeLTI aims to change this focus. Community-Integrated Care I-HeLTI is based on a Developmental Origins of Health and Disease approach, which suggests that environmental factors (namely social determinants of health like poverty, racism, housing, and geographical location) interact with genes during conception, the pre- and postnatal and infancy periods, and early childhood to affect later health outcomes. The initiative has an international component in countries like China, India, and South Africa, as well as the World Health Organization. Several Indigenous projects are active in Canada, including Aunties Within Reach (AWR) in the Wood Buffalo region in Alberta. AWR is a collaborative partnership between the University of Alberta's Collaborative Applied Research for Equity in Health Policy and Systems (CARE) Lab and the Ihkapaskwa Collective. The CARE Lab is an applied health policy systems team that studies and designs, implements, and evaluates programs with community partners to develop locally tailored, context-based solutions. The Ihkapaskwa Collective is an Indigenous-founded and Indigenous-led nonprofit focused on providing accessible, community-centered reproductive healthcare. 'AWR is an excellent model of community-integrated care,' said Stephanie Montesanti, PhD, associate professor of public health at the University of Alberta, Edmonton, and head of the CARE Lab. The partnership is not only delivering reproductive health services directly in the community but also engaging with providers across health and social sectors, she explained. Stephanie Montesanti, PhD When Montesanti joined I-HeLTI, she wanted to explore the opportunity to bring the program to the Wood Buffalo regional municipality, where Sheena Bradley, Ihkapaskwa founder and executive director, had been working. Sheena Bradley Bradley, a Cree-Métis full-spectrum birth worker and clinical herbalist, cofounded AWR with Maddie Amyotte, a Cree-Métis registered Indigenous midwife, and Shelby Weiss, a Sturgeon Bay Cree full-spectrum birth worker. Bradley said that AWR provides reproductive health support that mirrors the way that traditional 'aunties' would, when and where mothers, families, and the community needed it most. But funding has been tight. 'The CARE Lab reached out to us to partner on the I-HeLTI initiative, and we spent a good portion of a year building relationships and learning what the research would look like in our community,' said Bradley. 'Would it be led by us and families and elders in the community?' she said. 'There's a few elders on that team from various communities that are really helping guide [the CARE Lab's] research and what they see fits as research being brought into the community,' said Bradley. 'But there's also natural guidance from our grandmothers, the elders that we work with every day, and the families we support. That's what is meant by the phrase 'guided by community.'' The goal was to bridge the gap and improve access to reproductive health services, said Montesanti. Indigenous Birth Practices Since the 1960s, Canada has relied on maternal evacuation, which transfers Indigenous pregnant women from Canada's rural, remote regions to urban hospitals to give birth. The strategy was created to address disparities in maternal and child outcomes. It has been linked, however, to emotional, social, and cultural harms, as well as maternal and neonatal infections. 'Within our municipality, which is massive in land size and home to 13 First Nations and Métis communities, a lot of mothers are evacuated for birth, leave their home community and their support systems to come into town, where they are then scrutinized for not having healthy supports,' said Bradley. 'As soon as they leave their nation and go into town to deliver their baby, they are placed under Provincial rather than Tribal Child Family Services. It's hard to navigate between the two and figure out who's responsible for who and what,' she added. 'You can imagine when people are coming from a remote community to an urban center and hospital setting, it's going to be uncomfortable.' 'These services are offered by the mainstream health system, which is not necessarily culturally safe or culturally relevant,' added Montesanti. On the other hand, full-spectrum birth workers are both aunties and care providers. 'They play important roles around social, cultural, and outreach support, as well as [providing] mentorship and traditional teachings related to reproductive health, like breast or infant feeding, postpartum care, mental health and well-being, and social well-being,' she explained. The CARE Lab ensures an ongoing cycle of implementation learning (ie, identifying best practices, linking volunteers to them, identifying similar programs that have been implemented in other contexts, and bringing the lessons they offer to AWR). In alignment with I-HeLTI requirements, the lab also is creating a pregnancy cohort. AWR is stretched to capacity. In addition to Bradley and Amyotte, a Métis nurse practitioner runs a private primary care practice and has hospital privileges in Fort McMurray. Carlee Myette, a Métis auntie navigator or all-around advocate, guides families through basic needs supports like housing, food, mental health referrals, and navigating Child and Family Services. Kaylen Duke, a Chipewyan Prairie Dene, is community engagement coordinator and research assistant and operates as a liaison between the Aunties and the CARE Lab team, which, in addition to Montesanti, includes research assistant Nicole Orji, a First Nations Iroquois. Kaylen Duke 'What can be a model for other communities is the fact that AWR is helping to reclaim traditional practices and knowledge; it's bringing culture and ceremony back to birth,' said Orji. 'Many of our nations are matrilineal. Through the process of reconciliation and the mainstream Western medicine model, we have lost not just our mothers, but Indigenous people in general have lost our autonomy, choices, rights, and control over our reproductive freedoms,' she said. 'A lot of the work that the Aunties Within Reach program is doing is repairing some of those harms,' said Orji. Nicole Orji Gabel, Montesanti, Orji, Bradley, and Duke reported having no relevant financial relationships.
Yahoo
2 hours ago
- Yahoo
EFry Releases Region's First Study on Women's Homelessness & Housing Needs Thanks to $100,000 OTF Grant
"No Place of Their Own" Report: Women & Children Form More than Half the Homeless Population BRAMPTON, ON, June 25, 2025 /CNW/ - EFry Hope and Help for Women today released its report on the Peel Region's first-ever study of housing insecurity faced by women and single-caregiver led families: No Place of Their Own: Report on Women's Growing Homelessness and Housing Needs in the Peel Region. "As the Minister of Women's Social and Economic Opportunities, I am proud that our government invested in the Elizabeth Fry Hope and Housing study. These findings mark an important step forward in addressing the urgent and complex issue of housing insecurity for women and single-caregiver families in Peel. This report, supported by the Ontario Trillium Foundation, will help drive meaningful, targeted solutions that ensure women and children receive the care, safety, and support they deserve. I commend EFry for their vital work and remain committed to working together to build a system that truly meets the needs of our communities," said Charmaine Williams, MPP for Brampton Centre. EFry's study was made possible thanks to a $100,000 Resilient Communities Fund grant from the provincial government's Ontario Trillium Foundation (OTF). The grant funded the hiring of expertise, as well as the administrative and program costs associated with a scoping study establishing the need for shelter and housing for low-income women and children. The study brought together both qualitative and quantitative methodology, including regional, provincial and federal data relating to risk factors associated with homelessness and housing insecurity. "As a charity supporting vulnerable women and children, we have seen a dramatic increase in the number of homeless women and families," said Deborah Riddle, EFry Hope and Help's executive director. "While the housing crisis is well-known, there was no research into the depth of impact for women and their families. That information is vital in creating effective solutions. "The through-line in our findings is that supports for people experiencing homelessness are set-up for men, and what women need differs. With women and children now making up some 52 percent of the homeless population, we need to see changes in what's provided if we don't want the challenges to keep getting worse." Key Findings: Women & children form more than half the region's homeless population – 52 per cent of the Peel-Halton's homeless population is either a woman (40 per cent, up five per cent in the first few months of 2025) or a child (12 per cent). These may be lower than the true numbers, as homeless women are often hidden, living in tents, cars or couch-surfing. Only 2% of Peel's shelter beds are designated for women – Women will often avoid co-ed shelters due to personal security risks. All family shelters in the area are co-ed, putting children in potentially risky situations. More than 1/3 of Metro Toronto women live below the poverty line – Low-income thresholds for the region's municipalities are $29,380 for a single adult and $36,576 for two people, such as a mother and child. 29 per cent of women in Metro Toronto have incomes under $20,000, 37 per cent under $30,000, and nearly half earn less than $35,000. Average market rent would consume the vast majority of women's incomes – For women earning less than $30,000, the average market rent for a one-bedroom apartment consumes 68% of their income. A two-bedroom apartment for mother and child requires 81%. Even below-market rents are increasingly unaffordable and increasingly rare – The Canada Ontario Housing Benefit (COHB), intended to bridge the gap between low-income earners and average market rents, is not enough to fund housing in Peel, which averages nearly $1,000 month more than the Canadian Mortgage and Housing Corporation (CMHC) figure used to make the calculation. Wait times for subsidized housing in the region are commonly 13-15 years. There are no housing projects in development that will benefit the deeply poor – Current projects are targeted to those with annual incomes of $61,000 -$110,000. Best-practice supports for women differ from men – Housing stability increases when vulnerable people are provided with the right mix of supports. For men, these commonly address substance use, social isolation and employment skills. For women, they address safety and security, trauma and abuse, family-centred needs, education and job skills. The report's recommendations include: Develop an Enhanced COHB benefit of 150% for women and children exiting shelters to help them get and keep housing. Take a regional rather than municipal approach to housing, so people do not lose their place on affordable housing waitlists when they must move within the region. Open a dedicated shelter with beds for 40 women and children. Provide housing placement workers for shelters with women and children. Use federal Reaching Home funding to hire Family Homelessness Prevention Workers. Provide Community Integration Housing Workers exiting institutional care (prison, substance use treatment, hospital) to secure stable housing. Include family shelters in visiting teacher programs so homeless children stay attached to school. Conduct an annual regional count of homeless women and children in shelters. This information will support strategic support development and evaluation. No Place of Their Own: Report on Women's Growing Homelessness and Housing Needs in the Peel Region is available for download at EFry Hope and Help for Women is a Southern Ontario charity supporting women and children at risk or impacted by legal system involvement. For more than 50 years, its programs and services have helped clients build stable futures. About the Ontario Trillium Foundation The Ontario Trillium Foundation (OTF) is an agency of the Ontario government with a mission to build healthy and vibrant communities across the province. Last year, OTF invested nearly $105M into 732 community projects and multi-sector partnerships. Projects aim to enhance economic well-being, foster more active lifestyles, support child and youth development, provide spaces for people to come together and connect, and create a more sustainable environment. Visit to learn more. SOURCE EFry Hope and Help for Women View original content to download multimedia:
Yahoo
2 hours ago
- Yahoo
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind' or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, recently announced the enrollment of the first patient in its Phase I/IIa clinical trial for CMND-100, the Company's proprietary MEAI-based oral drug candidate for the treatment of Alcohol Use Disorder (AUD). The first patient was enrolled at Yale School of Medicine's Department of Psychiatry, marking a significant milestone in the trial. The trial is evaluating the safety, tolerability, and pharmacokinetic profile of CMND-100, with preliminary efficacy assessments to explore its potential in reducing alcohol cravings and consumption. This first-in-human study represents a pivotal step toward developing a groundbreaking treatment for individuals struggling with AUD. Eligible subjects for the clinical trial, among others, are individuals aged 18 to 60. Participants may be either non-treatment-seeking individuals who report heavy binge drinking (defined as at least five standard drinks in a day for men or at least four for women) on at least five days in the past month prior to screening, or treatment-seeking individuals diagnosed with Alcohol Use Disorder (AUD) per DSM-5 criteria, who report at least four binge drinking days in the month prior to screening. All subjects must express a desire to reduce or stop drinking. For more information: Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine said:'This advancement brings us one step closer to offering an innovative solution for those affected by AUD, a condition with significant unmet medical needs. The substance use disorder treatment market in the U.S. alone was valued at $35.1 billion in 2021 and is projected to grow to $60.2 billion by 2029. Moreover, there are hundreds of millions of individuals around the globe afflicted by AUD. However, the market has been constrained due to the limited effectiveness and adverse side effects of current treatment options. We are executing on our development strategy and are optimistic about the potential of our MEAI-based therapy to offer a safe, effective solution that can transform lives.' The Phase I/IIa clinical trial is being conducted at multiple sites, including Yale School of Medicine and Johns Hopkins University School of Medicine, while the Company is valuating additional clinical sites. Clearmind remains committed to advancing its robust intellectual property portfolio and pioneering psychedelic-derived therapeutics to address global health challenges. About Clearmind Medicine Inc. Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements. The Company's intellectual portfolio currently consists of nineteen patent families including 31 granted patents. The Company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio. Shares of Clearmind are listed for trading on Nasdaq under the symbol 'CMND' and the Frankfurt Stock Exchange under the symbol 'CWY0.' For further information visit: or contact: Investor Relationsinvest@ Telephone: (604) 260-1566US: CMND@ General InquiriesInfo@ Forward-Looking Statements: This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as 'expects,' 'anticipates,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates' and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses conducting its Phase I/IIa clinical trial, developing a treatment for individuals struggling with AUD, the size of the substance use disorder treatment market, executing its development strategy, valuating additional clinical sites, and that it remains committed to advancing its robust intellectual property portfolio and pioneering psychedelic-derived therapeutics to address global health challenges. The Company cannot assure that any patent will issue as a result of a pending patent application or, if issued, whether it will issue in a form that will be advantageous to the Company. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission ('SEC'), including, but not limited to, the risks detailed in the Company's annual report on Form 20-F for the fiscal year ended October 31, 2024 and subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Clearmind is not responsible for the contents of third-party websites.
